|Day Low/High||87.29 / 88.21|
|52 Wk Low/High||85.41 / 106.67|
CVS Pay offers an integrated checkout experience, combining pharmacy pick up, payment and ExtraCare into a single barcode scan
Jim Cramer says he doesn't like solar companies, but ICE is cool. Cable stocks, he says, are underrated.
Staying home is the new going out, and these companies are profiting, Cramer says.
CVS Health's (CVS) stock price target was reduced to $99 at Deutsche Bank on Monday.
The investment firm initiated coverage of Walgreens with a buy rating and a price target of $95 per share.
Cramer shares his views on Wells Fargo's suffering and what Best Buy could pull up. Kroger, CVS and Apple are among the stocks discussed.
While we didn't add any new names this week, we did use recent weakness in AT&T shares to build that position further.
An analysis of the data and what it means for the portfolio.
Plans feature a $0-deductible for drugs in all tiers, competitive premiums and affordable copays at a broad network of pharmacies nationwide
This group has become ridiculously cheap, but no one cares; watch Best Buy and TJX.
In the first week of the fourth quarter we continued our strategy of using stock-specific weakness to grow positions while improving our cost basis by adding to 2 names.
Automated messages provide important information about patients' prescriptions
We are buying more shares of CVS Health and Nike at attractive levels.
Cramer is sticking with Kroger and says to sell WhiteWave.
Here, innovation trumps fears of the global economy and even fears of the Federal Reserve, Cramer says.
This year hasn't gone Target's way, but its smaller-store format is one way it quietly is working to build a competitive edge for the long haul.
Action Alerts PLUS holdings are preparing for a smartphone showdown, while fellow holding Walgreens could see a boost to earnings.
Express Scripts will instead use Walgreens as the pharmacy of choice for the military healthcare plan Tricare.
As we close out September and the third quarter we have ample 'fire power' to continue improving the cost basis of current holdings and initiate new positions.
The investment firm reduced its target to $105 per share. CVS was trading at around $90 Friday.
Problems have hit some favorite names, but opportunities are becoming apparent.
CVS pharmacists in AL, AK, IL, MO, WV can now dispense naloxone to patients without an individual prescription, expanding company's program to 36 total states